Skip to main content
Retour
Watch Compare

Akso Health Group

Qualité des données : 100%
AHG
Nasdaq Services Business Services
2,29 €
▲ 0,03 € (1,33%)
Cap. Boursière: 1,93 B
Prix
2,25 €
Cap. Boursière
1,93 B
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Revenue grew 70,35% annually over 5 years — strong growth
Generating 7,23 M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 441,73%
Capital efficient — spends only 0,18% of revenue on capex

Croissance

Revenue Growth (5Y)
70,35%
Au-dessus de la moyenne du secteur (3,99%)
Revenue (1Y)512,08%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-68,03%
En dessous de la moyenne du secteur (-15,85%)
ROIC-65,92%
Net Margin-914,06%
Op. Margin-1126,52%

Sécurité

Debt / Equity
N/A
Current Ratio1,53
Interest CoverageN/A

Valorisation

PE (TTM)
-14,21
En dessous de la moyenne du secteur (-1,21)
P/B Ratio9,72
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Services (506 pairs)
Métrique Action Médiane du Secteur
P/E -14,2 -1,2
P/B 9,7 1,4
ROE % -68,0 -15,8
Net Margin % -914,1 -18,3
Rev Growth 5Y % 70,4 4,0
D/E — 0,4

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Estimations de Bénéfices

Aucune estimation prévisionnelle disponible

Surprises de Résultats

Derniers 4 trimestres
Trimestre BPA Est. BPA Réel Surprise
Q22019 0,00 € -0,45 € 0,0%
Q12019 -0,30 € 0,15 € +150,0%
Q42018 -0,78 € -0,60 € +23,1%
Q32018 N/A -1,08 € —

All Fundamental Metrics
Growth
Revenue Growth (1Y) 512,08% Revenue Growth (3Y) 5,88%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 70,35% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 14,84 M Net Income (TTM) -135,67 M
ROE -68,03% ROA -63,84%
Gross Margin 1,00% Operating Margin -1126,52%
Net Margin -914,06% Free Cash Flow (TTM) 7,23 M
ROIC -65,92% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1,53
Interest Coverage N/A Asset Turnover 0,07
Working Capital 6,37 M Tangible Book Value 180,41 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -14,21 Forward P/E N/A
P/B Ratio 9,72 P/S Ratio 129,87
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 0,38%
Market Cap 1,93 B Enterprise Value 1,92 B
Per Share
EPS (Diluted TTM) -0,16 Revenue / Share 0,02
FCF / Share 0,01 OCF / Share 0,01
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,18% FCF Conversion -5,33%
SBC-Adj. FCF 6,84 M Growth Momentum 441,73

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 14,78 M 2,41 M 13,18 M 6,31 M 1,75 M
Net Income -134,98 M -9,46 M -1,36 M -16,85 M -34,83 M
EPS (Diluted) -0,16 -0,07 -0,02 -0,28 -0,71
Gross Profit -281 526,0 122 132,0 1,27 M 916 226,0 —
Operating Income -166,30 M -8,64 M -14,27 M -15,94 M -30,90 M
EBITDA — — — — —
R&D Expenses — — — 421 186,0 441 405,0
SG&A Expenses 3,64 M — — — —
D&A 2,15 M — — 18 390,0 15 161,0
Interest Expense — 804 138,0 804 138,0 — —
Income Tax -30,80 M 24 988,0 17 549,0 131 433,0 482 976,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 214,95 M 142,02 M 20,46 M 50,68 M 31,69 M
Total Liabilities 15,80 M 3,59 M 11,62 M 38,39 M 14,41 M
Shareholders' Equity 199,12 M 138,37 M 8,73 M 12,28 M 17,27 M
Total Debt — — — — —
Cash & Equivalents 176,23 M 85,17 M 7,92 M 21,93 M 15,13 M
Current Assets 196,12 M 142,02 M 20,46 M 50,62 M 30,12 M
Current Liabilities 13,81 M 3,59 M 11,62 M 38,39 M 14,41 M